Atlas Trials

Randomized Trial of Plasma ctDNA Methylation-Guided Adjuvant Therapy in T4N0 and Low-Risk Stage III Colorectal Cancer

Clinical trial NCT07562503 · RECRUITING

Trial details

NCT number
NCT07562503
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
ctDNAColorectal CancerChemotherapy
Start date
2024-11-01
Primary completion
2027-12-31
Enrollment
340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.